|
|
||||||||
J Thorac Cardiovasc Surg 1998;115:1374-1376
© 1998 Mosby, Inc.
BRIEF COMMUNICATIONS |
Minneapolis, Minn., and Chicago, Ill.
From the Departments of Cardiology and Cardiovascular Surgery, University of Minnesota, Minneapolis, Minn., and Department of Cardiology, Children's Memorial Medical Center, Northwestern University Medical School, Chicago, Ill.
Received for publication Oct. 27, 1997 Revisions requested Nov. 5, 1997; revisions received Nov. 20, 1997. Accepted for publication Nov. 20. 1997. Address for reprints: Zahid Amin, MD, Children's Memorial Medical Center, Cardiology, Box 21, 2300 Children's Plaza, Chicago, IL 60614.
Isolated muscular ventricular septal defects (VSDs) account for 10% of VSDs. Among these, inlet and midmuscular VSDs are relatively easy to approach surgically, but apical and anterior muscular VSDs can be difficult to visualize during the operation.
1,2 Intraoperative closure of muscular VSDs with a device during cardiopulmonary bypass (CPB) has been described with good results.
3 The current report describes the use of a new transcatheter device to close muscular VSDs intraoperatively without using CPB in three dogs and later in an 8-month-old girl.
Animal studies
The Amplatz VSD device (AGA Medical Corporation, Golden Valley, Minn.) is a modified version of the Amplatz septal occlusion device.
4 It is made of fine nitinol wires that are woven into two discs with a connecting waist. The discs are filled with polyester to enhance thrombogenicity. The device is custom built to correspond to the size of the VSD and thickness of the ventricular septum. It has a screw mechanism on one side for connection to the delivery cable. The device is withdrawn into a loader before introduction into the delivery sheath.
All animals received humane care in compliance with the "Guide for the Care and Use of Laboratory Animals" (NIH Publication No. 86-23, revised 1985). The study protocol was approved by institutional animal care committee of the University of Minnesota.
To determine the feasibility of intraoperatively closing muscular VSDs, we created an anterior or apical VSD in three dogs with the help of a punch device. The diameter of the punch device was 10 mm.
With the animal under general endotracheal anesthesia and aseptic technique, the chest was entered by median sternotomy. The pericardium was opened. Two stay stitches were applied on the right ventricular free wall. A purse-string suture was placed on the left atrial appendage. The index finger of the left hand was inserted in the left atrium and advanced in the left ventricle. A right ventriculotomy was performed and the punch device inserted through the incision in the right ventricle. With a burring action, the septum was traversed until the punch device touched the index finger in the left ventricle. The punch was locked and removed, and the right ventriculotomy was closed with 5-0 running Prolene suture (Ethicon, Inc., Somerville, N.J.). The size of the defect was measured by epicardial echocardiography. In one dog two VSDs were created. An Amplatz VSD device that corresponded to the size of the VSD was screwed onto the delivery cable and withdrawn with the delivery sheath immersed in saline solution to avoid entrapment of air bubbles. The sheath was pushed through the right ventricular free wall. With the aid of epicardial echocardiographic guidance the sheath was aimed toward the muscular VSD. Once the sheath was across the VSD, the left disc was deployed in the left ventricle. The sheath was withdrawn and the right disc deployed in the right ventricle. The device was disconnected from the cable by counterclockwise rotation of the cable. Residual shunt was checked with the help of epicardial echocardiography.
Results
A total of four VSDs were created in three dogs. The smallest measured 7 mm and the largest 11 mm. Three muscular VSDs were closed during the operation and the fourth one in the catheterization laboratory. The first dog died 2 hours after the operation because of ventricular fibrillation. Dissection of the heart revealed the device in good position. The second dog was put to death after 3 months. Examination of the heart revealed the device in the optimal location with complete endothelialization. The third dog (with two devices) is still alive. Six months' follow-up echocardiogram and angiogram revealed no shunt.
Muscular VSDs in an 8-month-old baby
The operation was done on the basis of compassionate need. Informed consent and approval of the Institutional Review Board of the University of Minnesota, Minneapolis, were obtained before placement of the device.
|
Attempts were made to close the defect in the catheterization laboratory, but the procedure was unsuccessful because the defect could not be crossed with the wire. The baby was brought back to the operating room. A median sternotomy was performed and the size of the VSD measured by epicardial echocardiography (15 mm x 3 mm). With the heart beating, a 7F sheath was introduced through the right ventricular free wall. The sheath was guided across the defect with the aid ofepicardial echocardiography. The device was deployed as described earlier. There was no shunt by epicardial echocardiography after the deployment. Serial transthoracic echocardiograms obtained while the patient was in the intensive care unit revealed complete closure of the VSD. The baby was extubated 8 days later.
|
Muscular VSDs are difficult to close and have a high incidence of residual VSD, leading to multiple operations and increased morbidity and mortality. Left ventriculotomy has been advocated in the past but may lead to left ventricular dysfunction.
2 This is the first report that describes intraoperative closure of VSDs without the use of CPB with the Amplatz VSD device. This technique may be valuable in small infants in whom catheter manipulation is difficult. The advantages of the modified Amplatz device include complete retrievability, self-centering, small delivery system, malleability, and availability in several sizes. After successful animal studies,
5 more clinical trials are warranted.
References
This article has been cited by other articles:
![]() |
C. Gan, Q. An, K. Lin, H. Tang, R. C. Lui, K. Tao, W. Pan, and Y. Shi Perventricular device closure of ventricular septal defects: six months results in 30 young children. Ann. Thorac. Surg., July 1, 2008; 86(1): 142 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, M. Chen, Z. Qiu, J. Lu, and W. Wu A New Minimally Invasive Technique to Occlude Ventricular Septal Defect Using an Occluder Device Ann. Thorac. Surg., March 1, 2008; 85(3): 1067 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. J. Zeng, S. Q. Sun, X. F. Chen, X. J. Ma, Y. H. Luo, Y. P. Lim, and L. Tao Device Closure of Perimembranous Ventricular Septal Defects With a Minimally Invasive Technique in 12 Patients Ann. Thorac. Surg., January 1, 2008; 85(1): 192 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin Off-pump pulmonary valve placement. J. Thorac. Cardiovasc. Surg., November 1, 2006; 132(5): 1245 - 1246. [Full Text] [PDF] |
||||
![]() |
Z. Amin, R. Woo, D. A. Danford, S. E. Froemming, V. M. Reddy, J. Lof, and D. Overman Robotically assisted perventricular closure of perimembranous ventricular septal defects: Preliminary results in Yucatan pigs J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 427 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
B D Thanopoulos and M L Rigby Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder Heart, April 1, 2005; 91(4): 513 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin, D. A. Danford, J. Lof, K. F. Duncan, and S. Froemming Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: Preliminary results with the perventricular technique J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 234 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Bacha, Q.-L. Cao, J. P. Starr, D. Waight, M. R. Ebeid, and Z. M. Hijazi Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1718 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ootaki, M. Yamaguchi, N. Yoshimura, S. Oka, M. Yoshida, and T. Hasegawa Surgical management of trabecular ventricular septal defects: The sandwich technique J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 508 - 512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okubo, L. N. Benson, D. Nykanen, A. Azakie, G. Van Arsdell, J. Coles, and W. G. Williams Outcomes of intraoperative device closure of muscular ventricular septal defects Ann. Thorac. Surg., August 1, 2001; 72(2): 416 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin, X. Gu, J. M. Berry, J. L. Bass, J. L. Titus, M. Urness, Y.-M. Han, and K. Amplatz New Device for Closure of Muscular Ventricular Septal Defects in a Canine Model Circulation, July 20, 1999; 100(3): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Amin, X. Gu, J. M. Berry, J. L. Titus, S. S. Gidding, and A. P. Rocchini Periventricular closure of ventricular septal defects without cardiopulmonary bypass Ann. Thorac. Surg., July 1, 1999; 68(1): 149 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mace, P. Dervanian, E. Le Bret, T. A. Folliguet, V. Lambert, J. Losay, and J.-Y. Neveux ""Swiss cheese"" septal defects: surgical closure using a single patch with intermediate fixings Ann. Thorac. Surg., June 1, 1999; 67(6): 1754 - 1758. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |